作者: Xiaotian Kong , Huiyong Sun , Peichen Pan , Feng Zhu , Shan Chang
DOI: 10.1039/C7CP08241J
关键词:
摘要: Anaplastic lymphoma kinase (ALK) has been regarded as a promising target for the therapy of various cancers. A large number of ALK inhibitors with diverse scaffolds have been …